Blood purification in fulminant hepatic failure

Contributions to Nephrology

Volumn 166, Issue , 2010, Pages 64-72

  Shinozaki, Koichiro ^a   Oda, Shigeto ^a   Abe, Ryuzo ^a   Tateishi, Yoshihisa ^a   Yokoi, Takehito ^a   Hirasawa, Hiroyuki ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DETOXIFICATION; HUMAN; LIVER FAILURE; METHODOLOGY; MORTALITY; PLASMAPHERESIS; RENAL REPLACEMENT THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

HUMANS; LIVER FAILURE, ACUTE; PLASMA EXCHANGE; PLASMAPHERESIS; RENAL REPLACEMENT THERAPY; SORPTION DETOXIFICATION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84925934060     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000314854     Document Type: Article

References (30)

1. Polson J, Lee WM: AASLD position paper: the management of acute liver failure. Hepatology 2005;41:1179-1197.
2. Trey C, Lipworth L, Chalmers TC, et al: Fulminant hepatic failure: presumable contribution to halothane. N Engl J Med 1968;279:798-801.
3. Mas A, Rodes J: Fulminant hepatic failure. Lancet 1997;349:1081-1085.
4. Buckner CD, Clift RA, Volwiler W, et al: Plasma exchange in patients with fulminant hepatic failure. Arch Intern Med 1973;132:487-492.
5. Denis J, Opolon P, Nusinovici V, et al: Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane. Gut 1978;19:787-793.
6. Riordan SM, Williams R: Treatment of hepatic encephalopathy. N Engl J Med 1997;337:473-479.
7. Mochida S, Fujiwara K: Symposium on clinical aspects in hepatitis virus infection: recent advances in acute and fulminant hepatitis in Japan. Intern Med 2001;40:175-177.
8. O'Leary JG, Lepe R, Davis GL: Indications for liver transplantation. Gastroenterology 2008;134:1764-1776.
9. Fausto N, Campbell JS, Riehle KJ: Liver regeneration. Hepatology 2006;43: S45-S53.
10. Ring-Larsen H, Palazzo U: Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis. Gut 1981;22:585-591.
11. Jalan R, Pollok A, Shah SH, et al: Liver derived pro-inflammatory cytokines may be important in producing intracranial hypertension in acute liver failure. J Hepatol 2002;37:536-538.
12. Odeh M: Pathogenesis of hepatic encephalopathy: the tumour necrosis factor-alpha theory. Eur J Clin Invest 2007;37:291-304.
13. Rolando N, Wade J, Davalos M, et al: The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000;32:734-739
14. Davenport A, Will EJ, Davidson AM: Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med 1993;21:328-338.
15. Bernal W, Hall C, Karvellas CJ, et al: Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology 2007;46:1844-1852.
16. Ronco C, Tetta C, Mariano F, et al: Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs 2003;27:792-801.
17. Ronco C, Bellomo R, Homel P, et al: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000;356:26-30.
18. Leithead JA, Ferguson JW, Bates CM, et al: The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut 2009;58:443-449.
19. Yokoi T, Oda S, Shiga H, et al: Efficacy of high-flow dialysate continuous hemodiafiltration in the treatment of fulminant hepatic failure. Transfus Apher Sci 2009;40:61-70.
20. Lepore MJ, Martel AJ: Plasmapheresis with plasma exchange in hepatic coma: methods and results in five patients with acute fulminant hepatic necrosis. Ann Intern Med 1970;72:165-174.
21. Iwai H, Nagaki M, Naito T, et al: Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure. Crit Care Med 1998;26:873-876.
22. Sadahiro T, Hirasawa H, Oda S, et al: Usefulness of plasma exchange plus continuous hemodiafiltration to reduce adverse effects associated with plasma exchange in patients with acute liver failure. Crit Care Med 2001;29:1386-1392.
23. Yonekawa C, Nakae H, Tajimi K, et al: Effectiveness of combining plasma exchange and continuous hemodiafiltration in patients with postoperative liver failure. Artif Organs 2005;29:324-328.
24. Sadamori H, Yagi T, Inagaki M, et al: High-flow-rate haemodiafiltration as a brain-support therapy proceeding to liver transplantation for hyperacute fulminant hepatic failure. Eur J Gastroenterol Hepatol 2002;14:435-439.
25. Yoshiba M, Inoue K, Sekiyama K, et al: Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure. Artif Organs 1996;20:1169-1172.
26. Heemann U, Treichel U, Loock J, et al: Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 2002;36:949-958.
27. Ferenci P, Kramer L: MARS and the failing liver: Any help from the outer space? Hepatology 2007;46:1682-1684.
28. Demetriou AA, Brown RS Jr, Busuttil RW, et al: Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004;239:660-667.
29. Hirasawa H, Oda S, Matsuda K: Continuous hemodiafiltration with cytokine-adsorbing hemofilter in the treatment of severe sepsis and septic shock. Contrib Nephrol 2007;156:365-370.
30. Nakada TA, Oda S, Matsuda K, et al: Continuous hemodiafiltration with PMMA Hemofilter in the treatment of patients with septic shock. Mol Med 2008;14:257-263.